In summary, our findings indicate that quantitative assessment of tumor metabolism and microenvironment acidity through multi-pool Lorentzian analysis and pH-weighted analysis can serve as indicators for glioma grading, and for predicting IDH mutations, 1p/19q codeletion, and MGMT promoter methylation status. The gene discussed is MGMT; the disease is neoplasm.